[
  {
    "ts": null,
    "headline": "Top 50 High-Quality Dividend Growth Stocks For April 2025",
    "summary": "8 high-quality dividend stocks with top return potential for 2025. Click here for a detailed analysis.",
    "url": "https://finnhub.io/api/news?id=7e164db62b82712493c6c3ac3658c57e9cc854ca8b7bd166867e1c6f8ba49c6d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743722900,
      "headline": "Top 50 High-Quality Dividend Growth Stocks For April 2025",
      "id": 133701527,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2165465384/image_2165465384.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "8 high-quality dividend stocks with top return potential for 2025. Click here for a detailed analysis.",
      "url": "https://finnhub.io/api/news?id=7e164db62b82712493c6c3ac3658c57e9cc854ca8b7bd166867e1c6f8ba49c6d"
    }
  },
  {
    "ts": null,
    "headline": "Voya Corporate Leaders Trust Fund B Q4 2024 Commentary",
    "summary": "For the quarter, Voya Corporates Leaders Trust Fund Series B underperformed its benchmark, S&P 500 Index on a net asset value basis, primarily due to selection effects.",
    "url": "https://finnhub.io/api/news?id=748f3481ec49c2de282915ec9d756a88810d29de334c3771b85e2474e5315fc5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743722520,
      "headline": "Voya Corporate Leaders Trust Fund B Q4 2024 Commentary",
      "id": 133701497,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1761869533/image_1761869533.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "For the quarter, Voya Corporates Leaders Trust Fund Series B underperformed its benchmark, S&P 500 Index on a net asset value basis, primarily due to selection effects.",
      "url": "https://finnhub.io/api/news?id=748f3481ec49c2de282915ec9d756a88810d29de334c3771b85e2474e5315fc5"
    }
  },
  {
    "ts": null,
    "headline": "Shares of Sangamo Therapeutics Rally on Licensing Deal With Eli Lilly",
    "summary": "Shares of Sangamo Therapeutics Rally on Licensing Deal With Eli Lilly",
    "url": "https://finnhub.io/api/news?id=15e650d6627ab1afef50fab6f0596ba8355833094c355939abb6aa20508f4199",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743698700,
      "headline": "Shares of Sangamo Therapeutics Rally on Licensing Deal With Eli Lilly",
      "id": 133705183,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Shares of Sangamo Therapeutics Rally on Licensing Deal With Eli Lilly",
      "url": "https://finnhub.io/api/news?id=15e650d6627ab1afef50fab6f0596ba8355833094c355939abb6aa20508f4199"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly & Co. stock underperforms Thursday when compared to competitors",
    "summary": "Eli Lilly & Co. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=f3bf30a5e0c4d7051d6abb443519b95c6ca51ba578fb023c13170f28bd4598b0",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743697860,
      "headline": "Eli Lilly & Co. stock underperforms Thursday when compared to competitors",
      "id": 133705184,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly & Co. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=f3bf30a5e0c4d7051d6abb443519b95c6ca51ba578fb023c13170f28bd4598b0"
    }
  },
  {
    "ts": null,
    "headline": "Sangamo Therapeutics Enters Capsid License Agreement With Lilly",
    "summary": "Sangamo Therapeutics Enters Capsid License Agreement With Lilly",
    "url": "https://finnhub.io/api/news?id=b732458dfff5c876602d24fa781ae555a89c644edf7cc718097dbd2e6354a846",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743697800,
      "headline": "Sangamo Therapeutics Enters Capsid License Agreement With Lilly",
      "id": 133705185,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Sangamo Therapeutics Enters Capsid License Agreement With Lilly",
      "url": "https://finnhub.io/api/news?id=b732458dfff5c876602d24fa781ae555a89c644edf7cc718097dbd2e6354a846"
    }
  },
  {
    "ts": null,
    "headline": "BIIB's Experimental Alzheimer's Drug Gets FDA Fast Track Tag",
    "summary": "The FDA's fast track designation will facilitate rapid development and expedited review of Biogen's Alzheimer's disease candidate.",
    "url": "https://finnhub.io/api/news?id=45f13dc2652f61e0ea1627320908e91a237ee432e708856e48db630703054bfe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743691680,
      "headline": "BIIB's Experimental Alzheimer's Drug Gets FDA Fast Track Tag",
      "id": 133698065,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The FDA's fast track designation will facilitate rapid development and expedited review of Biogen's Alzheimer's disease candidate.",
      "url": "https://finnhub.io/api/news?id=45f13dc2652f61e0ea1627320908e91a237ee432e708856e48db630703054bfe"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market? - There Is Only One Winner",
    "summary": "Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market? - There Is Only One Winner",
    "url": "https://finnhub.io/api/news?id=7567bd4a26b1ef7720adc6e39994b0bfb5a0d22993435f8442f501f4c0176b4d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743688274,
      "headline": "Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market? - There Is Only One Winner",
      "id": 133698789,
      "image": "",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=7567bd4a26b1ef7720adc6e39994b0bfb5a0d22993435f8442f501f4c0176b4d"
    }
  },
  {
    "ts": null,
    "headline": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
    "summary": "Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.",
    "url": "https://finnhub.io/api/news?id=c402b362cc0772d387e0f0d179d153c70f25c81ed2a2858a113bb6a50deabdcf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743685209,
      "headline": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
      "id": 133697673,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.",
      "url": "https://finnhub.io/api/news?id=c402b362cc0772d387e0f0d179d153c70f25c81ed2a2858a113bb6a50deabdcf"
    }
  },
  {
    "ts": null,
    "headline": "Knownwell Connects with LillyDirect to Increase Access to Independent Comprehensive Metabolic Care Options for Patients Across the U.S.",
    "summary": "BOSTON - knownwell, an in-person and virtual, weight-inclusive primary care and metabolic health company, today announced it will be listed as the latest care provider option on Eli Lilly and...",
    "url": "https://finnhub.io/api/news?id=041388654298f02dfcf7e32ca9d6fdb9a1c0fda19d3e016d80e24d7db3c1f304",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743667094,
      "headline": "Knownwell Connects with LillyDirect to Increase Access to Independent Comprehensive Metabolic Care Options for Patients Across the U.S.",
      "id": 133696203,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "BOSTON - knownwell, an in-person and virtual, weight-inclusive primary care and metabolic health company, today announced it will be listed as the latest care provider option on Eli Lilly and...",
      "url": "https://finnhub.io/api/news?id=041388654298f02dfcf7e32ca9d6fdb9a1c0fda19d3e016d80e24d7db3c1f304"
    }
  }
]